Related Experiment Video
Updated: Jun 16, 2026
08:42
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
Published on: February 11, 2022
Clinical mid-term results after tricuspid valve replacement
Giorgio Viganò1, Andrea Guidotti, Maurizio Taramasso
1Cardiac Surgery, San Raffaele University Hospital, Milan, Italy. gcm.vigano@virgilio.it
Interactive Cardiovascular and Thoracic Surgery
|February 12, 2010
Summary
Tricuspid valve replacement (TVR) carries high risks, especially in critically ill patients. This study identified key predictors of mortality and factors influencing quality of life after TVR.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Disease
- Medical Outcomes Research
Background:
- Tricuspid valve replacement (TVR) is frequently performed in high-risk, critically ill patients, often requiring re-intervention.
- High mortality and morbidity rates are associated with TVR procedures.
Purpose of the Study:
- To analyze the outcomes of TVR, focusing on identifying risk factors for mortality.
- To evaluate mid-term survival rates and quality of life (QoL) post-TVR using the Short-Form 36 Health Survey (SF-36).
Main Methods:
- Retrospective analysis of 81 consecutive patients undergoing TVR between January 1992 and May 2007.
- Data collected included patient demographics, etiology, comorbidities, procedural details, hospital mortality, and mid-term follow-up.
- Quality of life was assessed using the SF-36 questionnaire.
Main Results:
- Hospital mortality was 9.88%. Five-year survival was 68%.
- Predictors of hospital mortality included atrial fibrillation (AFib), associated left-sided procedures, and preoperative right heart failure symptoms.
- SF-36 scores were influenced by age, associated procedures, previous cardiovascular surgery, left ventricle ejection fraction (LVEF), venous congestion, and pulmonary artery pressures (PAPs).
Conclusions:
- TVR in this cohort had significant hospital mortality and moderate mid-term survival.
- Risk factors for mortality and QoL post-TVR were identified, highlighting the complexity of managing these high-risk patients.
Related Concept Videos
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:23Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...